Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Kennedy's FDA Continues Big Pharma Corruption
December 25, 2025 Brandon Novick Back in February, newly-confirmed Secretary of Health and & Human Services (HHS) Robert F. Kennedy Jr. promised to reverse decades of industry capture of the public health agencies. Yet, recent moves by the Food &…
Missouri Pharmacy Association talks latest Trump deal with Big Pharma - Missourinet
The Missouri Pharmacy Association is examining the latest deal President Trump has reached with the pharmaceutical industry. Nine drug makers — Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck…
Sun Pharma arm recalls over 17,000 units of antifungal shampoo in US: USFDA
Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US due to manufacturing issues, according to the US Food and Drug Administration (USFDA). According to its latest Enforcement…
Ascendis Pharma A/S $ASND Shares Sold by Harbor Capital Advisors Inc.
Harbor Capital Advisors Inc. reduced its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 70.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 23,003 shares of the biotechnology…
Ascendis Pharma A/S (NASDAQ:ASND) Given Average Recommendation of 'Buy' by Analysts
Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) have been given a consensus rating of 'Buy' by the seventeen research firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the…
Royalty Pharma PLC $RPRX Stock Holdings Lifted by Voya Investment Management LLC
Voya Investment Management LLC increased its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 20.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The…
Ascendis Pharma A/S (NASDAQ:ASND) Receives Average Recommendation of 'Buy' from Analysts
Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has earned an average recommendation of 'Buy' from the seventeen analysts that are covering the company, MarketBeat reports. One research analyst has rated the stock with a sell rating, fourteen…
ARS Investment Partners LLC Decreases Stock Position in Ascendis Pharma A/S $ASND
ARS Investment Partners LLC reduced its holdings in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 16.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional…
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Sees Significant Drop in Short Interest
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totaling 254 shares, a…
As Trump's tariffs hit Indian fox nuts, the superfood eyes new markets
Katihar, India – Ravjit Singh, a leather garment trader who lives in Denver, Colorado, has started to feel the pinch of 50 percent tariffs imposed by United States President Donald Trump on Indian goods in recent months. The 50-year-old…
Lilly vs. Novo Nordisk: Who Will Lead India's Growing Obesity-Drug Market?
U.S.-based Eli Lilly & & Co. (LLY) and Danish drug maker Novo Nordisk (NVO) are competing to record a big part of India's quickly growing weight problems drug market. Lilly's Mounjaro takes on Novo's Ozempic and Wegovy as leading GLP-1 agonists.
Growth Stocks To Consider - December 24th
Prologis Stock Surges: Why the Rally May Continue Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to…
Beximco Pharmaceuticals (LON:BXP) Shares Pass Above 50 Day Moving Average - What's Next?
Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) shares crossed above its fifty day moving average during trading on Wednesday. The stock has a fifty day moving average of GBX 41.80 and traded as high as GBX 45. Beximco Pharmaceuticals…
America's Higher Education Promise Is Dead
December 25, 2025 Sean Carlton Education was sold as a guarantee for decades. A college degree represented stability and a future for those who followed the rules of a country that claims to reward preparation. That promise has collapsed under the…
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
Novo Nordisk A/S ADR (NVO), a trailblazer in the weight-loss revolution, has endured a bruising 2025. The Danish pharma giant has been hit by trimmed growth forecasts, pricing pressure, rising competition from Eli Lilly (LLY), mass layoffs…
Receive a Daily briefing on Pharma Industry News
Get Started